Clinical trial
Study of 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure Using Artificial Neural Network
NCT01826760 is registered in ClinicalTrials.gov with Wenzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure Using Artificial Neural Network
- Lead sponsor
- Wenzhou Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- June 30, 2010
- Enrollment
- 583 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute-on-chronic hepatitis b liver failure